A detailed history of Knott David M Jr transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Knott David M Jr holds 135,853 shares of EDIT stock, worth $177,967. This represents 0.16% of its overall portfolio holdings.

Number of Shares
135,853
Previous 177,000 23.25%
Holding current value
$177,967
Previous $827,000 44.01%
% of portfolio
0.16%
Previous 0.33%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$3.39 - $5.96 $139,488 - $245,236
-41,147 Reduced 23.25%
135,853 $463,000
Q2 2024

Aug 12, 2024

BUY
$4.67 - $7.28 $172,790 - $269,360
37,000 Added 26.43%
177,000 $827,000
Q1 2024

May 14, 2024

BUY
$7.03 - $11.07 $984,200 - $1.55 Million
140,000 New
140,000 $1.04 Million

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.